Human Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship with Clinicopathological Characteristics.

about

Human Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship with Clinicopathological Characteristics.

Item

http://www.wikidata.org/entity/Q36636356

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Human Epidermal Growth Factor ...... opathological Characteristics.

@ast

Human Epidermal Growth Factor ...... opathological Characteristics.

@en

type

Item

label

Human Epidermal Growth Factor ...... opathological Characteristics.

@ast

Human Epidermal Growth Factor ...... opathological Characteristics.

@en

prefLabel

Human Epidermal Growth Factor ...... opathological Characteristics.

@ast

Human Epidermal Growth Factor ...... opathological Characteristics.

@en

P1476

Human Epidermal Growth Factor ...... opathological Characteristics.

@en

P2093

Anahita Nosrati

http://www.w3.org/2001/XMLSchema#string

Shadi Tahvildari

http://www.w3.org/2001/XMLSchema#string

Zhila Torabizadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Four years incidence rate of colorectal cancer in Iran: a survey of national cancer registry data - implications for screening.

HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression

Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors

HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series.

Expression of HER2 in colorectal cancer does not correlate with prognosis.

HER2 testing in gastric cancer.

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer.

Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies.

The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.

P304

24-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15171/MEJDD.2016.03

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26933478

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4773079

http://www.w3.org/2001/XMLSchema#string